Equities

JMDC Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

JMDC Inc

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded720.00
  • 1 Year change--
  • Beta1.3521
Data delayed at least 15 minutes, as of Sep 17 2025 13:05 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

JMDC Inc. is a Japan-based company mainly engaged in the health big data business, telemedicine business and dispensing pharmacy support business. The Company operates in three business segments. The Health Big Data segment is engaged in the provision of receipt data analysis and health promotion solutions, and personal health information platforms, the build, management and analysis of medical databases such as receipt data and medical examination data, the build and sale of drug databases, and the development and provision of systems using drug databases for medical institutions. The Telemedicine segment is engaged in the provision of remote image diagnosis matching services, and infrastructure systems for remote image diagnosis. The Dispensing Pharmacy Support segment is engaged in the development and provision of business systems and electronic medication record for dispensing pharmacies, as well as the operation of dispensing pharmacies.

  • Revenue in JPY (TTM)47.61bn
  • Net income in JPY6.77bn
  • Incorporated2002
  • Employees2.28k
  • Location
    JMDC Inc2F, Kojimachi 311 Bldg, 3-1, KojimachiMINATO-KU 105-0012JapanJPN
  • Phone+81 357335010
  • Fax+81 357335101
  • Websitehttps://www.jmdc.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4483:TYO since
announced
Transaction
value
Dream Catcher IncDeal completed07 Nov 202507 Nov 2025Deal completed-22.27%--
Data delayed at least 15 minutes, as of Feb 10 2026 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.